ArticleExperimental and therapeutic medicine2025
Functional benefits of ultra-high hydrostatic pressurized brown rice on cognition, apathy, and bone health in older adults: A 12-month randomized controlled trial.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Age-related cognitive and psychological impairments are frequently accompanied by bone mineral density decline in older adults. Ultra-high hydrostatic pressurized brown rice (UBR) may support cognitive and bone health; however, the interplay between these domains remains unclear. The present randomized controlled trial aimed to examine the effects of daily UBR consumption for 12 months on cognitive function, mental health and bone status in community-dwelling older adults. In this study, 44 participants aged 65-85 years were randomly assigned to either a white rice (WR) group or a UBR group. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and the Cognitive Assessment for Dementia, iPad version (CADi). Apathy and depressive symptoms were evaluated using the Starkstein Apathy Scale and the Zung Self-Rating Depression Scale, respectively. The calcaneal bone area ratio was assessed using quantitative ultrasound and expressed as a percentage of the young adult mean (%YAM). At 12 months, the UBR group showed significantly higher MMSE scores compared with the WR group after adjustment for baseline values and age (P=0.046), although change scores were not significantly different. CADi total scores increased and execution time decreased significantly in the UBR group (P<0.05). Apathy scores were also significantly lower in the UBR group (P=0.008). Additionally, %YAM was significantly higher in the UBR group, and partial correlations indicated significant associations between cognitive, apathy and bone health indicators. No adverse events were reported. These findings suggest that daily UBR consumption may help preserve cognitive and motivational functions and support bone health in older adults. Further investigation in larger, prospectively registered trials is warranted. This study was retrospectively registered in February 2024, at UMIN Clinical Trials Registry as UMIN000053587.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.